Synapse - Works

Results (4640)

A phase II trial of LEE011 in combination with everolimus in the treatment of advanced well differentiated neuroendocrine tumors of foregut origin

Meeting Abstract

Raj, N. P.; Kelly, V.; Chan, J. A.; Dasari, A.; Capanu, M.; Tang, L.; Reidy, D. L.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Survival of chemotherapy (chemo) refractory gastric or gastroesophageal junction cancer (GC/GEJC) patients from Flatiron Health (FH): Matched clinical characteristics to ATTRACTION-2 and CHECKMATE-032

Meeting Abstract

Janjigian, Y. Y.; Le, D. T.; Ott, P. A.; Korytowsky, B.; Le, H.; Le, T. K.; Zhang, Y.; Sanchez, T.; Maglinte, G.; Laurie, M.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Efficacy outcomes with bevacizumab added to chemotherapy (bev + CT) compared with chemotherapy alone (CT) in left- and right-sided tumors in metastatic colorectal cancer (mCRC)

Meeting Abstract

Loupakis, F.; Hurwitz, H. I.; Saltz, L.; Arnold, D.; Grothey, A.; Nguyen, Q. L.; Osborne, S.; Yau, L.; Talbot, J.; Srock, S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Targeted next-generation sequencing (NGS) of germline DNA to identify genetic predisposition to gastric cancer (GC) in patients with CDH1-mutation negative early-onset (EO) or familial GC (FGC)

Meeting Abstract

Ku, G. Y.; Mukherjee, S.; Okoro, C.; Sharma, M.; Ravichandran, V.; Offit, K.; Joseph, V.; Janjigian, Y. Y.; Stadler, Z. K.; Kelsen, D. P.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Circulating tumor DNA (ctDNA) landscape and prognostic implications in advanced gastroesophageal adenocarcinoma (GEC)

Meeting Abstract

Maron, S. B.; Joshi, S. S.; Lomnicki, S.; Oliwa, T.; Landron, S.; Johnson, J.; Kiedrowski, L. A.; Nagy, R. J.; Lanman, R. B.; Janjigian, Y. Y.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

MORPHEUS: A phase Ib/II multi-trial platform evaluating the efficacy and safety of cancer immunotherapy (CIT)-based combinations in patients (pts) with gastric or pancreatic cancer

Meeting Abstract

Manji, G. A.; Bendell, J. C.; Oh, D. Y.; Kim, K. P.; Macarulla, T.; Ponz-Sarvisé, M.; Ajani, J. A.; Oberstein, P.; Janjigian, Y. Y.; Chau, I.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

RAINFALL: A randomized, double-blind, placebo-controlled phase III study of cisplatin (Cis) plus capecitabine (Cape) or 5FU with or without ramucirumab (RAM) as first-line therapy in patients with metastatic gastric or gastroesophageal junction (G-GEJ) adenocarcinoma

Meeting Abstract

Fuchs, C. S.; Shitara, K.; Di Bartolomeo, M.; Lonardi, S.; Al-Batran, S. E.; Van Cutsem, E.; Ilson, D. H.; Tabernero, J.; Chau, I.; Ducreux, M.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Nano-liposomal irinotecan and 5-FU/LV (N+F) for the treatment of advanced PDAC: Memorial Sloan Kettering (MSK) single cancer center evaluation

Meeting Abstract

Glassman, D. C.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

HALO 110-101: A phase Ib, randomized, open-label study of PEGPH20 (pegvorhyaluronidase alfa) in combination with cisplatin (CIS) + gemcitabine (GEM) (PEGCISGEM) or atezolizumab and CIS + GEM (PEGCISGEMATEZO) in hyaluronan-high subjects with locally advanced or metastatic cholangiocarcinoma and gallbladder cancer

Meeting Abstract

Borad, M. J.; Shroff, R. T.; Abou-Alfa, G. K.; Hecht, J. R.; Bullock, A. J.; Ritch, P. S.; Chondros, D.; Muhsin, M.; Oh, D. Y.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials

Meeting Abstract

Chau, I.; Chen, L. T.; Kang, Y. K.; Satoh, T.; Kato, K.; Chung, H. C.; Kang, W. K.; Chao, Y.; Chen, J. S.; Ott, P. A.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save